You have 9 free searches left this month | for more free features.

CIDP

Showing 1 - 25 of 99

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)

Active, not recruiting
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
May 17, 2023

Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP

Not yet recruiting
  • CIDP
  • IVIg
  • Nashville, Tennessee
    Vanderbilt University
Nov 4, 2022

RWE-based Treatment Patterns and Outcomes in CIDP

Not yet recruiting
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • +2 more
  • No intervention. Retrospective observation only.
  • Salford, United Kingdom
    Northern Care Alliance NHS Foundation Trust
Jul 7, 2023

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Worldwide (Rozanolixizumab)

Completed
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
  • Scottsdale, Arizona
  • +13 more
Mar 31, 2022

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial (Clinical examination, Functional scales, Walking test)

Not yet recruiting
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Clinical examination
  • +2 more
  • (no location specified)
Aug 5, 2022

Disease Activity in Chronic Inflammatory Demyelinating

Recruiting
  • CIDP
  • Smartwatch (Withings Scanwatch)
  • Duesseldorf, Northrhine-Westphalia, Germany
    Medical Faculty, Heinrich-Heine-University
Feb 1, 2023

Chronic Inflammatory Demyelinating Polyneuropathy Trial in Boca Raton, Austin (Batoclimab 680 milligrams (mg) subcutaneous (SC)

Recruiting
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly
  • +2 more
  • Boca Raton, Florida
  • +1 more
Jan 31, 2023

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy Trial (Panzyga)

Not yet recruiting
  • Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
  • (no location specified)
Sep 2, 2022

CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune

Recruiting
  • CIDP
  • +2 more
  • Intravenous immune globulin G
  • Subcutaneous immune globulin G
  • New Brunswick, New Jersey
    Rutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022

Spinal Cord Injuries Trial in Sugar Land (HB-adMSCs)

No longer available
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • HB-adMSCs
  • Sugar Land, Texas
    Hope Biosciences Stem Cell Research Foundation
Sep 20, 2022

Chronic Inflammatory Demyelinating Polyneuropathy Trial in Atlanta (VitalStim 400, VitalStim400)

Recruiting
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • VitalStim 400
  • VitalStim400
  • Atlanta, Georgia
    Center for Advanced Pediatrics, Children's Healthcare of Atlanta
Sep 2, 2022

GAMMAGARD LIQUID in Chronic Inflammatory Demyelinating

Active, not recruiting
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
    • Durham, North Carolina
      RTI Health Solutions
    Jun 14, 2022

    Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Multifocal Motor Neuropathy (MMN) Trial in Japan (TAK-771)

    Recruiting
    • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
    • Multifocal Motor Neuropathy (MMN)
    • Nagoya, Aichi, Japan
    • +16 more
    Feb 2, 2023

    Anti-aging Trial in Rio De Janeiro (Topical serum)

    Completed
    • Anti-aging
    • Topical serum
    • Rio De Janeiro, Brazil
      CIDP Brasil
    Sep 28, 2023

    CIDP Trial in Ulm (Immunoadsorption, Immunoglobulins)

    Not yet recruiting
    • CIDP
    • Immunoadsorption
    • Immunoglobulins
    • Ulm, Baden-Württemberg, Germany
      Department of Neurology, University of Ulm
    Sep 28, 2021

    Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial in Canada, United States (IgPro10)

    Recruiting
    • Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
    • IgPro10
    • Phoenix, Arizona
    • +8 more
    Mar 24, 2022

    UVA Protection Factors of SPF 50 and 50+ Face Sunscreens

    Completed
    • Ultraviolet-Induced Change in Normal Skin
      • Campinas, Brazil
      • +5 more
      Oct 4, 2023

      CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS

      Completed
      • Atopic Dermatitis
      • Cosmetic study
      • Rio de Janeiro, Brazil
        CIDP
      Mar 13, 2023

      Polyneuropathy, Impairments and Physical Activity - The

      Not yet recruiting
      • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      • +8 more
      • Validity and reliability of outcome measures in polyneuropathy
      • Healthy controls
      • (no location specified)
      Sep 15, 2023

      Antibody-mediated Rejection, NMO Spectrum Disorder, TTP Trial in Iowa City

      Recruiting
      • Antibody-mediated Rejection
      • +3 more
        • Iowa City, Iowa
          DeGowin blood Center
        Oct 31, 2022

        Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial (Rozanolixizumab)

        Available
        • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
        • (no location specified)
        Aug 19, 2021

        Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Japan (Rituximab (genetical recombination), Placebo)

        Completed
        • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
        • Rituximab (genetical recombination)
        • Placebo
        • Nagoya, Aich, Japan
        • +3 more
        Aug 19, 2021

        Guillain-Barre Syndrome Trial in Durham (Peripheral nerve ultrasound, Measurement of strength)

        Enrolling by invitation
        • Guillain-Barre Syndrome
        • Peripheral nerve ultrasound
        • Measurement of strength
        • Durham, North Carolina
          Duke University Hospital
        Sep 20, 2022

        The Benefit ofDeep Cleansing Gel in Management of Mild to

        Completed
        • Acne
        • Deep Cleansing Gel
        • Rio de Janeiro, Brazil
          CIDP
        Oct 14, 2022

        Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (SAR445088 (IV), SAR445088 (SC))

        Recruiting
        • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
        • SAR445088 (IV)
        • SAR445088 (SC)
        • Los Angeles, California
        • +28 more
        Aug 24, 2022